bf/NASDAQ:FHTX_icon.jpeg

NASDAQ:FHTX

Foghorn Therapeutics Inc.

  • Stock

4.16

−0.95%

−0.82

USD last updated 08/08 02:05:20

Last Close

4.98

07/08 20:00

Market Cap

265.58M

Beta: 2.16

Volume Today

63.52K

Avg: 76.72K

PE Ratio

−1.07

PFCF: −0.97

OverviewFinancialsAPI

This will be loaded shortly.

Loading

This is also still loading.

This will be loaded shortly.

Loading

This is also still loading.

This will be loaded shortly.

Loading

This is also still loading.

    Description

    Foghorn Therapeutics Inc., a clinical-stage biopharmaceutical company, discovers and develops medicines targeting genetically determined dependencies within the chromatin regulatory system. The company uses its proprietary Gene Traffic Control platform to identify, validate, and potentially drug targets within the system. It is developing FHD-286, a small molecule inhibitor of ...Show More

    Excel Tearsheet

    Earnings

    Earnings per Share (Estimate*)

    -3-2-12019-06-292020-03-312022-03-102024-03-142024-11-07

    Revenue (Estimate*)

    5M10M15M2019-06-292020-03-312022-03-102024-03-142024-11-07

    *Estimate based on analyst consensus